Why Did Carlos Slim Buy PBF Energy?
Carlos Slim made a splash in a surprising sector last…
Sell
23
ZVSA Quote, Financials, Valuation and Earnings
Last price:
$1.24
Seasonality move
:
-0.51%
Day range:
$1.05 - $1.12
52-week range:
$0.98 - $25.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.36x
Volume:
58.1K
Avg. volume:
238.1K
1-year change:
-87.61%
Market cap:
$2.6M
Revenue:
--
EPS (TTM):
-$113.75
Earnings Data
Next earnings date for ZVSA
--
Most recent earnings per share
-$2.43
Missed by $0.83
(Sep 30/2024)
Consensus Estimate
-$1.60
(Sep 30/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ZVSA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | -- | -- | -- | -$0.40 | -- |
| 12/31/2024 | Q4 | -- | -- | -- | -$2.73 | -- |
| 09/30/2024 | Q3 | -- | -- | -$2.43 | -$1.60 | -$0.83 |
| 06/30/2024 | Q2 | -- | -- | -$33.10 | -$3.75 | -$29.35 |
| 03/31/2024 | Q1 | -- | -- | -$45.30 | -$3.70 | -$41.60 |
| 12/31/2023 | Q4 | -- | -- | -$32.92 | -$21.40 | -$11.52 |
| 09/30/2023 | Q3 | -- | -- | -$30.18 | -$56.00 | $25.82 |
| 06/30/2023 | Q2 | -- | -- | -$1,694.12 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$1,358.80 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$177.37 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$515.54 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$35.00 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$54.17 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$28.45 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$27.16 | -- | -- |
ZyVersa Therapeutics Earnings Questions
-
How Much did ZyVersa Therapeutics Generate in Revenue Last Quarter?
ZyVersa Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did ZyVersa Therapeutics Beat Earnings Last Quarter?
ZyVersa Therapeutics announced earnings per share of -$2.43 which represents a miss of analyst forecast a -$1.60 per share.
-
Is ZyVersa Therapeutics Profitable?
ZyVersa Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for ZyVersa Therapeutics EPS Next Year?
ZyVersa Therapeutics's earnings are forecast to decrease from -$1,089.70 per share to -$12.43 per share next year representing a decrease of -98.86%.
-
When is ZyVersa Therapeutics's Earnings Date?
Currently, ZyVersa Therapeutics has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on April 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Booking Holdings Stock Undervalued?
There is a lot of humdrum in the market about…
Broadcom vs American Express: Which Is Best?
Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 116x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Sell
47
DRUG alert for Jan 3
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Buy
88
BMA alert for Jan 3
Banco Macro SA [BMA] is up 0.88% over the past day.
Sell
50
AGFY alert for Jan 3
Agrify [AGFY] is down 5.86% over the past day.
